Cite
MLA Citation
P.J. Ross et al.. “A phase I/II dose finding study evaluating the safety and tolerability of capecitabine and aflibercept in patients with unresectable metastatic colorectal cancer deemed unsuitable for doublet/triplet chemotherapy: results of the phase I study.” European journal of cancer, vol. 72, n.d., pp. S69–S70. http://access.bl.uk/ark:/81055/vdc_100041522134.0x000011